These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37963481)

  • 1. [Pulmonary hypertension associated with lung disease].
    Halank M; Zeder KE; Sommer N; Ulrich S; Held M; Köhler T; Foris V; Heberling M; Neurohr C; Ronczka J; Holt S; Skowasch D; Kneidinger N; Behr J
    Pneumologie; 2023 Nov; 77(11):916-925. PubMed ID: 37963481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaskuläre Dyspnoe: Pulmonale Hypertonie].
    Serény D; Ulrich S; Berlier C
    Ther Umsch; 2023 Aug; 80(6):272-278. PubMed ID: 37855531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Pulmonary Hypertension Associated with Chronic Lung Disease.
    Blanco I; Hernández-González F; García A; Torres-Castro R; Barberà JA
    Semin Respir Crit Care Med; 2023 Dec; 44(6):826-839. PubMed ID: 37487524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung disease-associated pulmonary hypertension - what the future holds.
    Cottin V; Diesler R; Turquier S; Valenzuela C
    Curr Opin Pulm Med; 2023 Sep; 29(5):406-415. PubMed ID: 37417835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
    Krishtopaytis E; Ampnti SA; Obeidat M; Ramahi N; Lane J; Toth D; Paul D; Tonelli AR
    Am J Cardiol; 2023 Nov; 207():363-369. PubMed ID: 37778225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hypertension associated with lung disease].
    Richter MJ; Tello K
    Herz; 2023 Aug; 48(4):274-279. PubMed ID: 37106074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
    Sato T; Furukawa T; Teramachi R; Fukihara J; Yamano Y; Yokoyama T; Matsuda T; Kataoka K; Kimura T; Sakamoto K; Ishii M; Kondoh Y
    Thorax; 2024 Apr; 79(5):422-429. PubMed ID: 38316550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    King CS; Shlobin OA
    Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
    Weatherald J; Nathan SD; El-Kersh K; Argula RG; DuBrock HM; Rischard FP; Cassady SJ; Tarver J; Levine DJ; Tapson VF; Deng C; Shen E; Das M; Waxman AB
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38519114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in chronic obstructive and interstitial lung diseases.
    Andersen CU; Mellemkjær S; Nielsen-Kudsk JE; Bendstrup E; Hilberg O; Simonsen U
    Int J Cardiol; 2013 Oct; 168(3):1795-804. PubMed ID: 23849967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary hypertension associated with left heart disease (group 2)].
    Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
    Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.
    Zimmermann GS; von Wulffen W; Huppmann P; Meis T; Ihle F; Geiseler J; Leuchte HH; Tufman A; Behr J; Neurohr C
    Respirology; 2014 Jul; 19(5):700-6. PubMed ID: 24697923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.